MOONLAKE IMMUNOTHERAPEUTICS MLTX
CLASS A ORD · Common Stock · CUSIP 61559X104
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $5.21.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2022 | 1 |
| Q2 2022 | 24 |
Biggest buyers
| BVF INC/IL | New | +21.8m |
| Cormorant Asset Management, LP | New | +6.1m |
| CITADEL ADVISORS LLC | New | +2.7m |
| FMR LLC | New | +1.2m |
| TCG Crossover Management, LLC | New | +1.0m |
| PRICE T ROWE ASSOCIATES INC /MD/ | New | +870.5k |
| BlackRock Inc. | New | +741.9k |
| RTW INVESTMENTS, LP | New | +500.0k |
| GREAT POINT PARTNERS LLC | New | +432.0k |
| TANG CAPITAL MANAGEMENT LLC | New | +319.0k |
Biggest sellers
| MARSHALL WACE, LLP | Sold out | -653.9k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| BIOTECHNOLOGY VALUE FUND L P 13D · may seek influence -2.6 pts · filed 2026-06-29 | 19.7% |
| Deep Track Capital, LP 13G · passive investor +3.3 pts · filed 2026-08-14 | 9.7% |
| T. Rowe Price Investment Management, Inc. 13G · institution new · filed 2026-08-14 | 5.3% |
Fell to 5% or below in the last year: Cormorant Asset Management, LP (4.3%, 2026-08-14)
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 2 | $4.3m | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2022-04-05 | Chen Bihua 10% owner · See footnote | Bought | $28.5m2.9m shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| BVF INC/IL 5.51% of their portfolio | 21.8m $114.2m | New |
| Cormorant Asset Management, LP 2.40% of their portfolio | 6.1m $30.9m | New |
| CITADEL ADVISORS LLC 0.02% of their portfolio | 2.7m $13.9m | New |
| FMR LLC 0.00% of their portfolio | 1.2m $6.3m | New |
| TCG Crossover Management, LLC 2.23% of their portfolio | 1.0m $5.2m | New |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 870.5k $4.4m | New |
| BlackRock Inc. 0.00% of their portfolio | 741.9k $3.9m | New |
| RTW INVESTMENTS, LP 0.07% of their portfolio | 500.0k $2.6m | New |
| GREAT POINT PARTNERS LLC 0.58% of their portfolio | 432.0k $2.3m | New |
| TANG CAPITAL MANAGEMENT LLC 0.25% of their portfolio | 319.0k $1.7m | New |
| Ghost Tree Capital, LLC 1.08% of their portfolio | 300.0k $1.6m | New |
| Monashee Investment Management LLC 0.38% of their portfolio | 200.0k $1.1m | New |
| CITIGROUP INC 0.00% of their portfolio | 159.1k $835.0k | New |
| UBS Group AG 0.00% of their portfolio | 73.7k $387.0k | New |
| ALPS ADVISORS INC 0.00% of their portfolio | 31.3k $164.0k | New |
| TD Asset Management Inc 0.00% of their portfolio | 29.0k $152.0k | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 28.1k $147.0k | New |
| Meridian Wealth Management, LLC 0.01% of their portfolio | 27.0k $142.0k | New |
| COWEN AND COMPANY, LLC 0.01% of their portfolio | 16.2k $85.0k | New |
| BARCLAYS PLC 0.00% of their portfolio | 15.1k $79.0k | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 11.8k $62.0k | New |
| Penserra Capital Management LLC 0.00% of their portfolio | 3.2k $16.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 25 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |